Anthrogenesis Corporation

Celularity Inc.

Antrhogenesis Corporation

Clarity Acquisition II LLC

Jennifer Paredes

Eric Law

Vladimir Jankovic

James W Edinger

Stewart Abbot

Jia-Lun Wang

Kristen S Labazzo

Aleksandar Francki

Neerav Dilip Padliya

Aleksandr Kaplunovsky

Robert J Hariri

Kathy Karasiewicz-Mendez

Andrew Morschauser

Allan Reduta

Ivana Djuretic

Aleksander Francki

Kathy E Karasiewicz-mendez

Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.

Placenta-derived adherent cell exosomes and uses thereof

Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.

Angiogenesis using placental stem cells

Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.

Amnion derived adherent cells

Growing community of inventors

Bloomfield, NJ, United States of America

Jennifer Paredes